Latest News

  • 25 Feb 2015

    TapImmune Appoints John Bonfiglio as Strategic Advisor

    Accomplished Biotech CEO to provide Capital Market, Financing and Drug Development Expertise SEATTLE, Feb. 25, 2015 - TapImmune Inc. (TPIV) has pleasure in announcing the appointment of John Bonfiglio, Ph.D., MBA as a Strategic Advisor.  John is a highly successful Biotech CEO with broad...

    more >

  • 23 Feb 2015

    TapImmune Appoints Patrick D. Yeramian, MD, Consulting Medic...

    SEATTLE, Feb. 23, 2015 – TapImmune, (TPIV), an immunotherapy company specializing in the development of immunotherapeutics for the treatment of cancer including metastatic disease, is pleased to announce Patrick D. Yeramian, MD, MBA, has been appointed Consulting Medical Director. He will...

    more >